Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Basic Research in Cardiology
|
September 3, 2024
Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients
Giuseppe Panuccio, Pierpaolo Correale, Maria d'Apolito, et al.
International Journal of Cancer
|
February 10, 2007
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma
Stefano Landi, Federica Gemignani, Monica Neri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2018
Scientific Advances and New Frontiers in Mesothelioma Therapeutics
Luciano Mutti, Tobias Peikert, Bruce W S Robinson, et al.
Mutation Research
|
March 17, 2015
Expression status of candidate genes in mesothelioma tissues and cell lines
Ombretta Melaiu, Erika Melissari, Luciano Mutti, et al.
Cancers
|
March 28, 2024
Impact of Center Volume on Cardiopulmonary and Mortality Outcomes after Immune-Checkpoint Inhibitors for Cancer: A Systematic Review and Meta-Analysis
Mohamed Rahouma, Nathan Mynard, Massimo Baudo, et al.
Biology Direct
|
April 18, 2023
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo
Monica Benvenuto, Valentina Angiolini, Chiara Focaccetti, et al.
Mutation Research
|
September 16, 2009
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism
Federica Gemignani, Monica Neri, Fabio Bottari, et al.
Genes & Cancer
|
April 25, 2017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
Ombretta Melaiu, Calogerina Catalano, Chiara De Santi, et al.
Journal of Cellular and Molecular Medicine
|
April 18, 2020
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach
Marcella Barbarino, Daniele Cesari, Maria Bottaro, et al.
Scientific Reports
|
June 11, 2017
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
Chiara De Santi, Ombretta Melaiu, Alessandra Bonotti, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Basic Research in Cardiology
|
September 3, 2024
Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients
Giuseppe Panuccio, Pierpaolo Correale, Maria d'Apolito, et al.
International Journal of Cancer
|
February 10, 2007
Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma
Stefano Landi, Federica Gemignani, Monica Neri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2018
Scientific Advances and New Frontiers in Mesothelioma Therapeutics
Luciano Mutti, Tobias Peikert, Bruce W S Robinson, et al.
Mutation Research
|
March 17, 2015
Expression status of candidate genes in mesothelioma tissues and cell lines
Ombretta Melaiu, Erika Melissari, Luciano Mutti, et al.
Cancers
|
March 28, 2024
Impact of Center Volume on Cardiopulmonary and Mortality Outcomes after Immune-Checkpoint Inhibitors for Cancer: A Systematic Review and Meta-Analysis
Mohamed Rahouma, Nathan Mynard, Massimo Baudo, et al.
Biology Direct
|
April 18, 2023
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo
Monica Benvenuto, Valentina Angiolini, Chiara Focaccetti, et al.
Mutation Research
|
September 16, 2009
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism
Federica Gemignani, Monica Neri, Fabio Bottari, et al.
Genes & Cancer
|
April 25, 2017
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
Ombretta Melaiu, Calogerina Catalano, Chiara De Santi, et al.
Journal of Cellular and Molecular Medicine
|
April 18, 2020
PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach
Marcella Barbarino, Daniele Cesari, Maria Bottaro, et al.
Scientific Reports
|
June 11, 2017
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
Chiara De Santi, Ombretta Melaiu, Alessandra Bonotti, et al.
Page
of 13